Cellumen, a drug discovery specialist based in Pittsburgh, has closed a Series B funding round, raising $8 million from Safeguard Scientifics
Cellumen, a drug discovery specialist based in Pittsburgh, has closed a Series B funding round, raising $8 million from Safeguard Scientifics
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.